beta-d-adenosine
Small moleculeexperimental
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Mar 1, 2012 (NCT01482169)
Timeline
No events for the selected filters.
Chemistry & pharmacology
Loading structure…
SMILES
Nc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O- Mol. weight
- 267.25 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
- Delivery
- Parenteral
- Availability
- Prescription Only
Oral
No
Parenteral
Yes
Topical
No
Sources
- ChEMBLCHEMBL477 ↗
Also known as
- (2r,3r,4s,5r)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol
- (2r,3r,4s,5r)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol
- 6-amino-9-beta-d-ribofuranosyl-9h-purine
- 6-amino-9-beta-d-ribofuranosyl-9h-purine
- 9-beta-d-ribofuranosidoadenine
- 9-beta-d-ribofuranosidoadenine
- 9-beta-d-ribofuranosyl-9h-purin-6-amine
- 9-beta-d-ribofuranosyl-9h-purin-6-amine
- adenin riboside
- adenin riboside
- adenocard
- adenocard
- adenocor
- adenocor
- adenocor
- adenoscan
- adenoscan
- adenoscan
- adenoscan
- adenosin
- adenosin
- adenosina
- adenosina
- adenosine
- adenosine
- adénosine
- adénosine
- adenosinum
- adenosinum
- adenyldeoxyriboside
- adenyldeoxyriboside
- ade-rib
- ade-rib
- beta-d-adenosine
- beta-d-adenosine
- beta-d-adenosine
- sr-96225
- sr-96225
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01482169 | N/A | Mar 1, 2012 | Astellas, Ochsner Health System |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Astellas | For profit | 1 | 0 | 1 | 2012 |
| Ochsner Health System | Academic/Hospital | 1 | 1 | 1 | 2012 |
2 organizations
Page 1 / 1